Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA)
The Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) program provides funding for state agencies to expand or enhance access to medication assisted treatment (MAT) services for individuals with opioid use disorder. The goals of the program are to:
- Increase the number of admissions for MAT
- Increase the number of clients receiving integrated care/treatment
- Decrease illicit opioid drug use at 6-month follow-up
- Decrease the use of prescription opioids in a non-prescribed manner at 6-month follow-up
Eligibility is limited to 17 states identified with having the highest rates of primary treatment admissions for heroin and opioids per capita and includes those with the most dramatic increases for heroin and opioids, based on SAMHSA’s Treatment Episode Data Set (TEDS): 2007 – 2014. See Appendix E of the program guidance for the full list of eligible states.
Estimated award amount: Up to $2 million
per year for up to 3 years if using a certified EHR
system or if using a non-certified system but planning to
certify. Up to $1.9 million per year for up to 3 years if
not using a certified EHR system or using a non-certified
system with no plan to certify.
Estimated total funding: $28,000,000
Anticipated Number of Awards: Up to 5 awards
For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.